Abstract: The present invention provides a method for assisting a prediction of how likely a shunt trouble occurs, comprising a step of determining that the shunt trouble likely occurs, when a mevalonic acid concentration in a sample derived from a hemodialyzed patient is equal to or more than a preset cutoff value or increases with time.
Type:
Application
Filed:
September 27, 2019
Publication date:
February 10, 2022
Applicants:
ASAHI KASEI PHARMA CORPORATION, JAPAN COMMUNITY HEALTH CARE ORGANIZATION